These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33328252)

  • 1. Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici
    Grünig E; Benjamin N; Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Distler O
    Ann Rheum Dis; 2023 Mar; 82(3):e66. PubMed ID: 33328252
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Iudici M; Allali D; Porcher R
    Ann Rheum Dis; 2023 Mar; 82(3):e65. PubMed ID: 33328253
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
    Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Grünig E; Benjamin N; Distler O
    Ann Rheum Dis; 2020 Mar; 79(3):370-378. PubMed ID: 31818805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the diagnostic test accuracy of N-terminal pro-brain natriuretic peptide (NT-proBNP) for pulmonary arterial hypertension in patients with systemic sclerosis. Comment on: "Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: a systematic review and meta-analysis" by Zhang et al. Joint Bone Spine 2021:105287.
    Simopoulou T; Grammatikopoulou MG; Gkiouras K; Bogdanos DP
    Joint Bone Spine; 2022 May; 89(3):105317. PubMed ID: 34875375
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary hypertension phenotypes in patients with systemic sclerosis.
    Haque A; Kiely DG; Kovacs G; Thompson AAR; Condliffe R
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34407977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of tricuspid annular peak systolic velocity (s') measurement in scleroderma-associated pulmonary arterial hypertension: comment on the article by Gopal et al.
    Pansy J; Koestenberger M; Ravekes W
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1591. PubMed ID: 24692346
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
    Sasahara AA
    J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
    Lewis C; Sanderson R; Vasilottos N; Zheutlin A; Visovatti S
    Heart Fail Clin; 2023 Jan; 19(1):45-54. PubMed ID: 36435572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension.
    Gopal DM; Doldt B; Finch K; Simms RW; Farber HW; Gokce N
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1386-94. PubMed ID: 24515598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
    Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis.
    Jaafar S; Visovatti S; Young A; Huang S; Cronin P; Vummidi D; McLaughlin V; Khanna D
    Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31196948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: For Real?
    Xanthouli P
    Am J Respir Crit Care Med; 2023 Feb; 207(3):238-240. PubMed ID: 36383981
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension.
    Dorfmüller P; Montani D; Humbert M
    Eur Respir J; 2010 Jan; 35(1):6-8. PubMed ID: 20044455
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival in systemic sclerosis-related pulmonary arterial hypertension in the modern treatment era.
    Girgis RE; Mathai SC; Wigley FM; Hassoun PM
    Am J Respir Crit Care Med; 2009 Dec; 180(12):1280; author reply 1280-1. PubMed ID: 19949241
    [No Abstract]   [Full Text] [Related]  

  • 15. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and therapy of pulmonary hypertension in systemic sclerosis.
    Bull TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
    Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
    BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).
    Salerni R; Rodnan GP; Leon DF; Shaver JA
    Ann Intern Med; 1977 Apr; 86(4):394-9. PubMed ID: 848800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension: screening and evaluation in scleroderma.
    York M; Farber HW
    Curr Opin Rheumatol; 2011 Nov; 23(6):536-44. PubMed ID: 21934501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.